Pulling SEC filings + quote and writing the call…

My Size, Inc.
Next earnings ≈ Aug 13, 2026 · est. from filing cadence
Last earnings -1.9% on 2026-05-15
Cash-burning nano-cap fashion-tech roll-up with <1yr runway, relentless dilution, and no path to profit — uninvestable.
Cash & equivalents $2.30M · FY2025
My Size is a $2.2M nano-cap that has assembled a grab-bag of unrelated fashion businesses (Naiz Fit sizing tech, Orgad Amazon reselling, Percentil recommerce, Ten Peacks distribution) into an 'integrated platform' story. The numbers expose it: FY2025 revenue grew a respectable +13.4% to $9.36M, but gross profit actually FELL -9.7% to $3.00M (gross margin just 32%), meaning the growth is coming from low-quality, low-margin reselling revenue that dilutes the mix. Operating income was -$5.74M (a -61.3% operating margin) and net loss widened to -$5.85M, worse than FY2024's -$4.00M. Five straight years of losses have piled up a -$69.7M accumulated deficit against only $5.16M of equity.
The fatal problem is liquidity. Operating cash flow was -$5.14M for the year, yet cash and equivalents stand at just $2.30M — down 52.8% YoY — implying well under a year of runway at the current burn. The company plugs the gap by printing stock: shares outstanding jumped +128.3% in one year to 4.82M, and it is still issuing warrants to consultants and service providers (per the 10-K's Recent Sales of Unregistered Securities). Long-term debt also spiked +469% and total liabilities rose +60.2%. This is a business kept alive by serial dilution, and every existing shareholder is being ground down; ROE of -113.5% quantifies the value destruction.
Is MYSZ a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $131K | $4.46M | $7.00M | $8.26M | $9.36M |
| Gross profit | $131K | $634K | $2.73M | $3.32M | $3.00M |
| Operating income | -$10.6M | -$8.11M | -$6.74M | -$3.94M | -$5.74M |
| Net income | -$10.5M | -$8.31M | -$6.38M | -$4.00M | -$5.85M |
| Diluted EPS | — | -$7.47 | -$20.40 | -$4.39 | -$1.87 |
| Net margin | -8030.5% | -186.4% | -91.2% | -48.4% | -62.5% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Filed annual-meeting proxy; routine board/auditor/governance votes
Released Q1 FY26 results; revenue growth continued but operating losses persisted
Q1 FY26: growth continued but low cash and net losses signal ongoing burn
FY25: rev +13% to $9.4M but net loss widened to -$5.9M; cash -53%, shares +128%
Filed late-filing notice (NT 10-K) for the FY25 annual report
Announced FY25 results (rev +13% to $9.4M) with a Reg FD business update
Received Nasdaq notice of non-compliance with a continued-listing rule
Posted financial results and issued a Reg FD business update
Announced a change in executive officers/directors (leadership transition)
Sources: SEC EDGAR (CIK 0001211805, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/4/2026, 10:32:18 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:32 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-12-29 | Luzon Ronen Chief Executive Officer | Buy | 3.75K @ $0.78 | $2.92K |
| 2025-12-15 | Luzon Ronen Chief Executive Officer | Award | 215K | |
| 2025-12-15 | Luzon Ronen Chief Executive Officer | Award | 60.0K | |
| 2025-12-15 | Branitzky Oron Director | Award | 15.0K | |
| 2025-12-15 | Elmaliah Oren Chief Financial Officer | Award | 30.0K | |
| 2025-12-15 | Cembrero Saralegui Borja Chief Growth Officer | Award | 110K | |
| 2025-12-15 | Pardo Billy CPO & COO | Award | 60.0K | |
| 2025-12-15 | Pardo Billy CPO & COO | Award | 215K | |
| 2025-12-15 | Zimmerman Guy Director | Award | 15.0K | |
| 2025-12-15 | Golan Roy Director | Award | 15.0K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median